奥扎格雷与依达拉奉联合治疗急性脑梗塞30例临床研究  

Clinical Study 30 Cases of Acute Cerebral Infarction and Yinxingdamo Ozagrel Combination Therapy

作　　者：吴硕[1] 杜仁伟[1] 赵喆[1] 

机构地区：[1]安徽省淮南朝阳医院,232001

出　　处：《中国继续医学教育》2015年第8期202-203,共2页China Continuing Medical Education

摘　　要：目的评价奥扎格雷和依达拉奉联合用药治疗急性脑梗塞的安全性及有效性。方法将患者随机分为观察组和对照组,对照组采用依达拉奉进行治疗,观察组采用依达拉奉与奥扎格雷联合进行治疗。结果观察组总有效率与对照组相比,差异显著(χ2=6.67,P<0.01);观察组全血粘度与血小板凝聚率较对照组明显降低(P<0.05),具有统计学意义;两组患者经脑部CT检查,观察组患者病灶吸收出现好转与对照组相比明显提高(P<0.01)。结论奥扎格雷与依达拉奉联合用药治疗急性脑梗塞效果较好,患者临床症状改善明显,预后较为乐观,患者的生活质量得到明显提高。Objective To evaluate the safety and effectiveness of Ozagrel and edaravone combined treatment of acute cerebral infarction.Methods Patients were randomly divided into the observation group and the control group, the control group were treated with edaravone, the observation group with edaravone and ozagrel combined treatment.ResultsThe total efifciency of the observation group compared with the control group, the difference was signiifcant （χ^2=6.67,P〈0.01）, the observation group blood viscosity was signiifcantly lower （P〈 0.05）, the two groups of patients after brain CT examination, patients in the observation group were absorbed obviously improved compared with the control group improved （P〈0.01）. Conclusion Edaravone combined with ozagrel and drug treatment effect of acute cerebral infarction is better, the clinical symptoms were obviously improved, which has clinical application value.

关 键 词：奥扎格雷 依达拉奉 急性脑梗塞 

分 类 号：R743[医药卫生—神经病学与精神病学]